HR 6717 · 115th Congress · Health

Depression Side Effect Labeling Awareness Act of 2018

Introduced 2018-09-06· Sponsored by Rep. Rush, Bobby L. [D-IL-1]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the House Committee on Energy and Commerce.(2018-09-06)

Plain Language Summary

[AI summary unavailable — showing source text] Depression Side Effect Labeling Awareness Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act to require the label of a drug that has an increased risk of suicide or depression to prominently display such risk.…

Summarized by Claude AI · Non-partisan · For informational purposes only